Literature DB >> 10201971

Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.

T Roberts1, E C Snow.   

Abstract

Recruitment of the CD19/CD21 coreceptor is thought to lower the threshold for effective signaling through the B cell Ag receptor. We provide evidence supporting a second role for coreceptor recruitment, and that is to enhance the survival/proliferative potential of the responding B cells. We show that B cell Ag receptor signaling in the absence of coreceptor recruitment induces cellular accumulation of the anti-apoptotic protein Bcl-xL, whereas CD19-mediated signals are required for Bcl-2 accumulation. The expression of both anti-apoptotic proteins correlates with the enhanced responsiveness of both resting and cycling B cells to growth-promoting signals delivered through CD40. These results provide further evidence for the necessity of coreceptor recruitment during Ag-dependent B cell activation and indicate that Ags derived from inflammatory sites function as better thymus-dependent Ags than their counterparts not coated with complement fragments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201971

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity.

Authors:  Franklin R Toapanta; Ted M Ross
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  CD19 function in central and peripheral B-cell development.

Authors:  Christopher J Del Nagro; Dennis C Otero; Amy N Anzelon; Sidne A Omori; Ravi V Kolla; Robert C Rickert
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Increased immunogenicity and induction of class switching by conjugation of complement C3d to pneumococcal serotype 14 capsular polysaccharide.

Authors:  S T Test; J Mitsuyoshi; C C Connolly; A H Lucas
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.

Authors:  Joseph F Bower; Xinzhen Yang; Joseph Sodroski; Ted M Ross
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

5.  Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus.

Authors:  Zhenhua Zhang; Yongqing Li; Shufang Xu; Fuyong Chen; Li Zhang; Beiyu Jiang; Xiaoling Chen
Journal:  Virol J       Date:  2010-05-09       Impact factor: 4.099

6.  Uncoupling CD21 and CD19 of the B-cell coreceptor.

Authors:  Robert A Barrington; Thomas J Schneider; Lisa A Pitcher; Thorsten R Mempel; Minghe Ma; Natasha S Barteneva; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-12       Impact factor: 11.205

7.  Critical role of SHP2 (PTPN11) signaling in germinal center-derived lymphoma.

Authors:  Xin Jiang; Honggang Guo; Jianguo Wu; Qiang He; Yiqiao Li; Miao Wang; Hongyang Pan; Wande Li; Jinjie Wang; Qingqing Wang; Jing Shen; Yuehai Ke; Ren Zhou
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

8.  Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

Authors:  Thomas D Green; David C Montefiori; Ted M Ross
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Soluble CD23 controls IgE synthesis and homeostasis in human B cells.

Authors:  Alison M Cooper; Philip S Hobson; Mark R Jutton; Michael W Kao; Binia Drung; Boris Schmidt; David J Fear; Andrew J Beavil; James M McDonnell; Brian J Sutton; Hannah J Gould
Journal:  J Immunol       Date:  2012-03-05       Impact factor: 5.422

10.  Essential role of EBF1 in the generation and function of distinct mature B cell types.

Authors:  Bojan Vilagos; Mareike Hoffmann; Abdallah Souabni; Qiong Sun; Barbara Werner; Jasna Medvedovic; Ivan Bilic; Martina Minnich; Elin Axelsson; Markus Jaritz; Meinrad Busslinger
Journal:  J Exp Med       Date:  2012-04-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.